Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024
DOI: 10.1161/atvbaha.123.319852 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Lynn Willems und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, KU Leuven-University of Leuven, Belgium (L.W.…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Embolism, Thrombosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Abstract (Originalsprache)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonary hypertension characterized by the presence of organized thrombi that obstruct pulmonary arteries, ultimately leading to right heart failure and death. Among others, impaired angiogenesis and inflammatory thrombosis have been shown to contribute to the progression of CTEPH. In this review, we summarize the 2-faced nature of angiogenesis in both thrombus formation and resolution in the context of CTEPH and highlight the dual role of angiogenesis and neovascularization in resolving venous thrombi. Furthermore, we discuss relevant in vitro and in vivo models that support the benefits or drawbacks of angiogenesis in CTEPH progression. We discuss the key pathways involved in modulating angiogenesis, particularly the underexplored role of TGFβ (transforming growth factor-beta) signaling in driving fibrosis as an integral element of CTEPH pathogenesis. We finally explore innovative treatment strategies that target angiogenic pathways. These strategies have the potential to pioneer preventive, inventive, or alternative therapeutic options for patients with CTEPH who may not qualify for surgical interventions. Moreover, they could be used synergistically with established treatments such as pulmonary endarterectomy or balloon pulmonary angioplasty. In summary, this review emphasizes the crucial role of angiogenesis in the development of in fibrothrombotic tissue, a major pathological characteristic of CTEPH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, KU Leuven-University of Leuven, Belgium (L.W., J.V., M.D., R.Q.).
- Department of Cell and Chemical Biology (L.W., M.-J.G.), Leiden University Medical Centre, the Netherlands.
- Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Free University Medical Center, the Netherlands (K.K.).
- Department of Medicine-Thrombosis and Haemostasis (F.A.K.), Leiden University Medical Centre, the Netherlands.
- Clinical Department of Respiratory Diseases, University Hospital Leuven, Belgium (M.D., R.Q.).
ORCID-Profile: Lynn Willems, Janne Verhaegen, Frederikus A Klok, Marion Delcroix, Marie-José Goumans, Rozenn Quarck
Zitieren
APA
Willems, L., Kurakula, K., Verhaegen, J., Klok, F. A., Delcroix, M., Goumans, M. J., & Quarck, R. (2024). Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.319852
Vancouver
Willems L, Kurakula K, Verhaegen J, Klok FA, Delcroix M, Goumans MJ, et al. Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.123.319852
BibTeX
@article{Willems2024,
author = {Willems, Lynn and Kurakula, Kondababu and Verhaegen, Janne and Klok, Frederikus A and Delcroix, Marion and Goumans, Marie-José and Quarck, Rozenn},
title = {Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
doi = {10.1161/atvbaha.123.319852}
}
EUVIMED